Kathleen Senneca

Kathleen Senneca is an experienced healthcare sales professional currently serving as the Oncology/Immunology Key Account Manager at Fresenius Kabi, managing the San Francisco/Sacramento territory with a focus on new product launches and biologic biosimilars in Oncology and related specialties. Prior roles include Key Account Manager at Aimmune Therapeutics promoting the first FDA-approved oral immunotherapy for peanut allergy, and Account Executive positions at Scipher Medicine and Myriad Genetics, where Kathleen specialized in molecular diagnostics and biomarker tests for Rheumatology. With a solid foundation in various therapeutic areas including Gastroenterology, Pain Management, and Women’s Healthcare, Kathleen has built a track record in product promotion and territory development since earning a BS in Health Science/Nutrition from California State University - East Bay.